Blocking Tumor Signals May Improve Anti-Tumor Response

Blocking tumor driven signaling immune cells may improve a patient’s immune response to cancer, according to a study conducted by Matthew Farren, in the laboratory of Kelvin Lee, MD, Department of Immunology, Roswell Park Cancer Institute (RPCI). The research will be presented at the 2008 annual meeting of the American Society of Hematology, December 6-9, San Francisco, CA.

More: continued here

Filed under: Cancer on December 11th, 2008